The Market Reports

Synopsis

The global market for MIS Sacroiliac Joint Fusion was estimated to be worth US$ 365 million in 2024 and is forecast to a readjusted size of US$ 842 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on MIS Sacroiliac Joint Fusion cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time. Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.

The MIS sacroiliac (SI) joint fusion market is growing steadily, driven by the rising recognition of sacroiliac joint dysfunction as a source of chronic lower back pain. Leading manufacturers like SI-BONE, Medtronic, and Zimmer Biomet dominate the space with well-established implant systems and extensive clinical validation. Emerging players such as CoreLink and VGI Medical are differentiating through innovative fixation techniques and improved implant designs. The market is witnessing increased surgeon adoption of minimally invasive approaches due to reduced operative time, lower blood loss, and quicker recovery. Future trends point to the integration of navigation and robotic guidance systems to enhance precision, as well as biologic augmentation to promote faster fusion.

This report aims to provide a comprehensive presentation of the global market for MIS Sacroiliac Joint Fusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of MIS Sacroiliac Joint Fusion by region & country, by Type, and by Application.

The MIS Sacroiliac Joint Fusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MIS Sacroiliac Joint Fusion.

Market Segmentation

By Company

• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• RTI Surgical
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
• SIGNUS Medizintechnik

Segment by Type

• Minimally Invasive Surgery
• Open Surgery of Sacroiliac Joint Fusion

Segment by Application

• Hospitals
• ASC

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.